|14.89||-0.02 / -0.13%|
As of 3:59pm ET
|14.89||0.00 / 0.00%|
The 5 analysts offering 12-month price forecasts for Amicus Therapeutics Inc have a median target of 22.00, with a high estimate of 27.00 and a low estimate of 17.50. The median estimate represents a +47.75% increase from the last price of 14.89.
The current consensus among 5 polled investment analysts is to Buy stock in Amicus Therapeutics Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.